Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Responsive Arthroscopy reported engagement with 13 surgeons and other clinicians in the states MedaRep covers, worth $30K in consulting, speaking, meals and travel for its device products, the most in Colorado ($13K to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Colorado ($13K, 2 engaged), Minnesota ($7,695, 6 engaged), Florida ($4,860, 1 engaged), Iowa ($2,134, 1 engaged), North Carolina ($1,243, 2 engaged).
In the last ten years FDA made 13 decisions for Responsive Arthroscopy (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2019 (3). The latest was on 2026-07-20.
| Responsive Arthroscopy Stealth and Mini Stealth All-Suture Anchors |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Responsive Arthroscopy.